Drugging the Undruggable: Inhibiting MYCN Signalling
نویسندگان
چکیده
منابع مشابه
Targeting allosteric regulatory modules in oncoproteins: “Drugging the Undruggable”
Kinases are often aberrantly activated in various tumor types by overexpression, point mutations, chromosomal translocations and other mechanisms. Therefore, small molecule inhibitors that block the enzymatic activity of kinases have been developed for different targets and are successfully used for the treatment of cancer patients. A major drawback of these molecularly targeted therapies is th...
متن کاملDrugging the “undruggable” DNA-binding domain of STAT3
STAT3 (signal transducers and activators of transcription 3) is a transcription factor in the JAK/STAT signaling pathway in response to extracellular cytokines and growth factors [1]. STAT3 is constitutively activated in human malignancies and has been shown to play an important role in many facets of human cancers including oncogenesis, angiogenesis, metastasis, immune evasion, and EMT [2]. Th...
متن کاملDrugging Wnt signalling in cancer.
Aberrant regulation of the Wnt signalling pathway has emerged as a prevalent theme in cancer biology. This chapter summarizes the research that provides a proof of concept for inhibiting Wnt signalling in cancer, the potential means by which this could be achieved, and some recent advances towards this goal. A brief discussion of molecular diagnostics and possible safety concerns is also provided.
متن کاملThe challenge of drugging undruggable targets in cancer: lessons learned from targeting BCL-2 family members.
The genomic and proteomic revolutions have provided us with an ever-increasing number of mechanistic insights into cancer pathogenesis. Mutated genes and pathologic protein products have emerged as the basis for modern anticancer drug development. With the increasing realization of the importance of disrupting oncogenic protein-protein interaction, new challenges have emerged for classical smal...
متن کاملDrugging the Cancers Addicted to DNA Repair
Defects in DNA repair can result in oncogenic genomic instability. Cancers occurring from DNA repair defects were once thought to be limited to rare inherited mutations (such as BRCA1 or 2). It now appears that a clinically significant fraction of cancers have acquired DNA repair defects. DNA repair pathways operate in related networks, and cancers arising from loss of one DNA repair component ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Proceedings
سال: 2019
ISSN: 2504-3900
DOI: 10.3390/proceedings2019022098